We’re tracking in-house compensation. Take the Law360 Survey
Click here
USA v. Chan
-
June 27, 2018
Federal prosecutors cannot force the young-adult son of an insider trading suspect to testify against his father, the presiding judge ruled Wednesday on the third day of a securities fraud trial in Boston.
-
June 26, 2018
Shortly after his lawyer extolled his intelligence to a Massachusetts federal jury Tuesday morning, a former biostatistician at Akebia Therapeutics Inc. was ordered to spend a night in the custody of the U.S. Marshals Service after defying a federal judge's order by speaking to a witness who testified on the insider trading trial's opening day.
-
June 22, 2018
Two biostatisticians charged with insider trading cannot preclude prosecutors from saying "material, nonpublic information" at their imminent securities fraud trial in Boston, a federal judge ruled on Friday.
-
June 19, 2018
Two former biostatistician friends at Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. will face securities fraud charges for allegedly cashing in on nonpublic drug trial information, a federal judge in Massachusetts said Tuesday.
-
May 30, 2018
Federal prosecutors petitioned a judge Wednesday to ensure that, if the wife of a former director at Akebia Therapeutics Inc. refuses to testify against her husband at his insider-trading trial in Boston next month, the government can call an FBI agent to relay statements she has made about the alleged scheme.
-
November 16, 2017
A Massachusetts federal judge on Thursday refused to trim a lawsuit alleging insider trading by two former employees of Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc.
-
November 03, 2017
Prosecutors asked a Massachusetts federal court Friday to shoot down a request by two pharmaceutical employees to dismiss the insider trading charges against them, saying they had tried to sneak a challenge to the government's evidence into a procedural phase of the case.
-
October 24, 2017
Two former Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. employees on Monday asked a Massachusetts federal court to gut insider trading allegations against them, claiming neither traded securities based on nonpublic information that could reasonably affect Akebia stock.
-
October 12, 2017
A Boston judge decided Thursday to release a former pharmaceutical executive accused of insider trading while he awaits trial despite the court's concerns that the defendant's "Dr. Jekyll and Mr. Hyde" tendencies might reappear.
-
September 25, 2017
A Massachusetts federal magistrate judge on Monday said he would order an evaluation for a former pharmaceutical company insider trading suspect who was jailed for a series of increasingly bizarre stunts.